↓ Skip to main content

Cost-effectiveness of abemaciclib plus endocrine therapy in high-risk HR+/HER2–early breast cancer in China

Overview of attention for article published in Cost Effectiveness and Resource Allocation, November 2023
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

twitter
2 X users

Readers on

mendeley
6 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cost-effectiveness of abemaciclib plus endocrine therapy in high-risk HR+/HER2–early breast cancer in China
Published in
Cost Effectiveness and Resource Allocation, November 2023
DOI 10.1186/s12962-023-00499-9
Pubmed ID
Authors

Qiran Wei, YuTing Xu, Wei Liu, Xin Guan

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 1 17%
Student > Bachelor 1 17%
Unknown 4 67%
Readers by discipline Count As %
Medicine and Dentistry 2 33%
Pharmacology, Toxicology and Pharmaceutical Science 1 17%
Unknown 3 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 December 2023.
All research outputs
#16,940,853
of 24,911,633 outputs
Outputs from Cost Effectiveness and Resource Allocation
#343
of 504 outputs
Outputs of similar age
#91,884
of 180,537 outputs
Outputs of similar age from Cost Effectiveness and Resource Allocation
#2
of 17 outputs
Altmetric has tracked 24,911,633 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 504 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one is in the 24th percentile – i.e., 24% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 180,537 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.